Hanoi (VNA) – Vietnam has completed thefirst phase of the human trials of Nano Covax, a homegrown COVID-19 vaccine,with the participation of 60 volunteers, the Vietnam Military MedicalUniversity said on February 8.
The last 22 volunteers received the second shots, withtwo receiving the 50mgc dose, and 20 getting the 75mgc dose.
Experts said Nano Covax has proven safe and effective againstthe coronavirus SARS-CoV-2, even its new variant.
Most of the volunteers are in stable conditions after vaccination.Only few had light injection site pain and fever that disappeared after one to twodays.
The objective of the first phase is to evaluate thesafety of the vaccine, developed and manufactured by HCM City-based NanogenPharmaceutical Biotechnology JSC.
Nearly 400 people have registered for the second phasethat is expected to last for six months, during which 560 volunteers will beinjected.
The third phase will see the engagement of more than 10,000volunteers, beginning from August.
If the result is good, Vietnam would administer thevaccine to the public in early 2022./.